Byron McKinney - Concepedia

Author

Byron McKinney

Also Known As

B. McKinney, Byron McKinney

Publications

403

Citations

H-Index

Concepts

All Affiliations

Byron McKinney is an author at University of Alabama at Birmingham specializing in radiation oncology, immunology, and immunotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	115
2	Immunology	1	1	115
3	Immunotherapy	1	1	115
4	Oncology	1	1	115
5	Radiation Oncology	1	1	115

Byron McKinney

Publications

397

Citations

H-Index

Page 1

	Year	Citations
A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma E. Antonio Chiocca, Katie Smith, Byron McKinney, Molecular Therapy	2008	117
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma John P. Leonard, Jonathan W. Friedberg, Anas Younes, Annals of Oncology Anti-cd80 Monoclonal AntibodyLymphoid NeoplasiaPhase I/ii StudyMedicineImmunology	2007	115
Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study Charlotte A. Gaydos, Lisa E. Manhart, Stephanie N. Taylor, Journal of Clinical Microbiology	2019	63
Clinical Validation of the Aptima Bacterial Vaginosis and Aptima <i>Candida/Trichomonas</i> Vaginitis Assays: Results from a Prospective Multicenter Clinical Study Jane R. Schwebke, Stephanie N. Taylor, Ronald Ackerman, Journal of Clinical Microbiology	2019	59
Characteristics of Mycoplasma genitalium Urogenital Infections in a Diverse Patient Sample from the United States: Results from the Aptima Mycoplasma genitalium Evaluation Study (AMES) Lisa E. Manhart, Charlotte A. Gaydos, Stephanie N. Taylor, Journal of Clinical Microbiology	2020	31
Durable Responses in Patients Treated with Galiximab (Anti-CD80) in Combination with Rituximab for Relapsed or Refractory Follicular Lymphoma: Long-Term Follow-up of a Phase II Clinical Trial. Jonathan W. Friedberg, Anas Younes, David C. Fisher, Blood	2008	12

Page 1